Search for media from: "Kelda Tan"


NCC Chinese Patient on Tecentriq+Avastin

From  Kelda Tan 0 likes 5 plays 0  

The Major Breakthroughs in Lung Cancer 2020

Breakthroughs in Lung Cancer in 2020 - immunotherapy and targeted therapy

From  Kelda Tan 0 likes 34 plays 0  

Changing Landscape of PD-L1-high NSCLC treatments

Changing landscape for PD-L1-high NSCLC treatmentsSpeakers: Dr Ross Soo (Singapore, Moderator), Dr Mark Socinski (US, Speaker), Dr Roy Herbst (US, Speaker), Dr Yuh Min Chen (Taiwan,…

From  Kelda Tan 0 likes 158 plays 0  

Setting The Standards for 1st Line ALK NSCLC Treatment

Interactive case-study focused webinar to learn about:• Differences in survival, CNS control and toxicity profiles among current andemerging treatment specifically in the landscape of 1L ALK+…

From  Kelda Tan 0 likes 61 plays 0  

Solving the NSCLC Puzzle in the era of cancer immunotherapy

Agenda 1. Opening - Dr Tho Lye Mun (Malaysia) 2. Update on frontline NSCLC treatment in wake of immunotherapy approvals - Dr Florian Fuchs (Germany) 3. Making sense of it all - CIT strategy in…

From  Kelda Tan 0 likes 26 plays 0  

Global Vision: Immunotherapy in NSCLC (26May2020)

Prof Zhou Caicun (Shanghai Pulmonary Hospital, Tongji University School of Medicine Shanghai), Dr Ross Soo (National University Cancer Institute, Singapore) and a panel of Chinese oncologists were…

From  Kelda Tan 0 likes 25 plays 0